GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Monday, 26 Jan 2015 | 6:04 PM ET

    Amgen Inc. fell$. 08 or. 1 percent, to $159.73. Biogen Idec rose $4.91 or 1.4 percent, to $362.44. Celgene Corp. rose$. 23 or. 2 percent, to $124.12.

  • Jan 26- Pharmacy benefits manager EnvisionRx said on Monday it reached an agreement to provide its customers with Gilead Sciences Inc's hepatitis C drugs on an exclusive basis, the latest Gilead victory in a market share battle with AbbVie over their new treatments for the liver destroying virus. EnvisionRx said Gilead's Sovaldi and its newer two-drug...

  • Midday Glance: Biotechnology companies Monday, 26 Jan 2015 | 1:53 PM ET

    Amgen Inc. rose$. 26 or. 2 percent, to $160.07. Biogen Idec rose $3.25 or. 9 percent, to $360.78. Celgene Corp. rose$. 16 or. 1 percent, to $124.05.

  • Early Glance: Biotechnology companies Monday, 26 Jan 2015 | 12:16 PM ET

    Amgen Inc. fell$. 98 or. 6 percent, to $158.83. Biogen Idec fell$. 29 or. 1 percent, to $357.24. Celgene Corp. fell$. 56 or. 5 percent, to $123.33.

  • Final Glance: Biotechnology companies Friday, 23 Jan 2015 | 6:04 PM ET

    Amgen Inc. rose$. 24 or. 2 percent, to $159.81. Biogen Idec rose $3.88 or 1.1 percent, to $357.53. Celgene Corp. rose$. 18 or. 1 percent, to $123.89.

  • Midday Glance: Biotechnology companies Friday, 23 Jan 2015 | 1:31 PM ET

    Amgen Inc. fell$. 45 or. 3 percent, to $159.12. Biogen Idec rose $4.60 or 1.3 percent, to $358.25. Celgene Corp. rose$. 04 or percent, to $123.75.

  • Early Glance: Biotechnology companies Friday, 23 Jan 2015 | 11:24 AM ET

    Amgen Inc. fell$. 51 or. 3 percent, to $159.07. Biogen Idec rose $2.25 or. 6 percent, to $355.90. Celgene Corp. fell$. 73 or. 6 percent, to $122.98.

  • Final Glance: Biotechnology companies Thursday, 22 Jan 2015 | 6:05 PM ET

    Amgen Inc. rose $2.19 or 1.4 percent, to $159.57. Biogen Idec fell $8.18 or 2.3 percent, to $353.65. Celgene Corp. rose $1.49 or 1.2 percent, to $123.71.

  • Midday Glance: Biotechnology companies Thursday, 22 Jan 2015 | 1:29 PM ET

    Amgen Inc. rose$. 42 or. 3 percent, to $157.80. Biogen Idec fell $10.37 or 2.9 percent, to $351.46. Celgene Corp. fell$. 20 or. 2 percent, to $122.02.

  • Early Glance: Biotechnology companies Thursday, 22 Jan 2015 | 12:09 PM ET

    Amgen Inc. fell $2.08 or 1.3 percent, to $155.30. Biogen Idec fell $10.44 or 2.9 percent, to $351.39. Celgene Corp. fell $1.14 or. 9 percent, to $121.08.

  • Final Glance: Biotechnology companies Wednesday, 21 Jan 2015 | 6:01 PM ET

    Amgen Inc. fell$. 22 or. 1 percent, to $157.38. Biogen Idec fell $1.46 or. 4 percent, to $361.83. Celgene Corp. fell $1.03 or. 8 percent, to $122.22.

  • Midday Glance: Biotechnology companies Wednesday, 21 Jan 2015 | 1:22 PM ET

    Amgen Inc. rose$. 05 or percent, to $157.65. Biogen Idec rose$. 13 or percent, to $363.41. Celgene Corp. fell$. 83 or. 7 percent, to $122.42.

  • Early Glance: Biotechnology companies Wednesday, 21 Jan 2015 | 10:45 AM ET

    Amgen Inc. fell$. 68 or. 4 percent, to $156.93. Biogen Idec fell $2.04 or. 6 percent, to $361.24. Celgene Corp. fell$. 82 or. 7 percent, to $122.43.

  • Final Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 6:35 PM ET

    Amgen Inc. fell$. 83 or. 5 percent, to $157.60. Biogen Idec rose $10.53 or 3.0 percent, to $363.28. Celgene Corp. rose $1.44 or 1.2 percent, to $123.25.

  • Most active Nasdaq-traded stocks Tuesday, 20 Jan 2015 | 1:33 PM ET

    Advanced Micro Devices Inc. fell 6.3 percent to $2.24 with 56,007,000 shares traded. Apple Inc. rose 2.6 percent to $108.72 with 46,516,000 shares traded. Cisco Systems Inc. rose 1.4 percent to $28.07 with 33,360,500 shares traded.

  • Midday Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 1:33 PM ET

    Amgen Inc. fell $2.21 or 1.4 percent, to $156.22. Biogen Idec rose $3.65 or 1.0 percent, to $356.40. Celgene Corp. fell$. 30 or. 2 percent, to $121.51.

  • Early Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 10:33 AM ET

    Amgen Inc. fell $2.17 or 1.4 percent, to $156.26. Biogen Idec fell $1.29 or. 4 percent, to $351.46. Celgene Corp. fell$. 73 or. 6 percent, to $121.08.

  • Johnson & Johnson tops 4Q earnings expectations Tuesday, 20 Jan 2015 | 8:59 AM ET

    TRENTON, N.J.— The strong dollar and stiff competition for some products squeezed Johnson& Johnson in the fourth quarter and it missed Wall Street expectations for revenue, triggering a sell-off of its shares. Hospital admissions and surgeries are increasing, which boosted sales of Johnson& Johnson's surgical devices, wound care products and medicines, the...

  • TRENTON, N.J.— Drugmaker AbbVie Inc. said Monday that its new, all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries. The company said the European Commission granted marketing authorization for the combination of Viekirax and Exviera. It's already approved in EU nonmembers Switzerland, Norway, Iceland...

  • Aetna Inc. said Friday that it's reached a deal with Gilead bringing discounts for Sovaldi and Harvoni, which have list prices of about $84,000 and $94,000, respectively, for a course of treatment. Aetna's decision follows moves by two huge prescription benefit managers, Express Scripts Holdings Co. and CVS Health Corp., to wring big discounts from makers of a...